The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...
The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...
The FDA granted breakthrough therapy designation to privosegtor, a novel peptoid small molecule for the treatment of optic ...
Oculis (OCS) stock jumps as the FDA grants Breakthrough Therapy designation for its eye disease drug Privosegtor targeted at ...
If you're looking for an artsy aesthetic in your images, Lensbaby's Optic Swap system is a great place to start. From the Composer Pro II to the Sweet 50, these are the top housing and lens options we ...
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
This roundup highlights recent FDA updates related to drug approvals and devices used by optometric eye care professionals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback